Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trials. (Q35057222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

review article

1 reference

title

Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

M Clanet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

C Manelfe

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

17 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

139-144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Axonal transection in the lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Optimizing the association between disability and biological markers in MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

A magnetization transfer histogram study of normal-appearing brain tissue in MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Magnetic resonance spectroscopy: imaging axonal damage in MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

The value of new magnetic resonance techniques in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Whole-brain diffusion MR histograms differ between MS subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

Correlates of MS disability assessed in vivo using aggregates of MR quantities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900351-9

10.1016/S0022-510X(02)00351-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559501%20AND%20SRC:MED&resulttype=core&format=json